Legal Opinion

Athenex Pharma Solutions, LLC v. Azar, II

District Court, District of Columbia

Decided August 1, 2019No. Civil Action No. 2019-0603Published

1Opinion of the Court

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA _________________________________________ ) ATHENEX INC., et al., ) ) Plaintiffs, ) ) v. ) Case No. 19-cv-00603 (APM) ) ALEX M. AZAR II, et al. ) ) Defendants. ) _________________________________________ ) MEMORANDUM OPINION I. INTRODUCTION In 2013, Congress added Section 503B to the Food, Drug, and Cosmetic Act, creating a new category of drug manufacturer known as an “outsourcing facility.” Such facilities are permitted to sell large quantities of compounded drugs directly to hospitals and health care professionals without receiving…

2Cases cited22 opinions

  1. Chevron U. S. A. Inc. v. Natural Resources Defense Council, Inc.Supreme Court of the United States · 1984
  2. Motor Vehicle Mfrs. Assn. of United States, Inc. v. State Farm Mut. Automobile Ins. Co.Supreme Court of the United States · 1983
  3. Robinson v. Shell Oil Co.Supreme Court of the United States · 1997
  4. United States v. American Trucking AssociationsSupreme Court of the United States · 1940
  5. Food & Drug Administration v. Brown & Williamson Tobacco Corp.Supreme Court of the United States · 2000

17 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API